Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 10/20 | 0.69 |
| ▸ | LPL | P06858 | 9/20 | 0.69 |
| ▸ | P4HB | P07237 | 1/20 | 0.42 |
| ▸ | SNCA | P37840 | 1/20 | 0.40 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.40 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.39 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.37 |
| ▸ | KDR | P35968 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31683831 | 1.00 | LIPG (0.69) | LIPGLPLP4HBSNCADGAT1 | |
| SCHEMBL29664621 | 1.00 | LIPG (0.69) | LIPGLPLP4HBSNCADGAT1 | |
| SCHEMBL19106582 | 1.00 | LIPG (0.69) | LIPGLPLP4HBSNCADGAT1 | |
| SCHEMBL23327891 | 1.00 | LIPG (0.69) | LIPGLPLP4HBSNCADGAT1 | |
| SCHEMBL31576188 | 1.00 | LIPG (0.69) | LIPGLPLP4HBSNCADGAT1 | |
| SCHEMBL23327847 | 1.00 | LIPG (0.69) | LIPGLPLP4HBSNCADGAT1 | |
| SCHEMBL23327860 | 1.00 | LIPG (0.69) | LIPGLPLP4HBSNCADGAT1 | |
| SCHEMBL23327855 | 1.00 | LIPG (0.69) | LIPGLPLP4HBSNCADGAT1 | |
| SCHEMBL20489345 | 1.00 | LIPG (0.69) | LIPGLPLP4HBSNCADGAT1 | |
| SCHEMBL29518849 | 1.00 | LIPG (0.69) | LIPGLPLP4HBSNCADGAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024144215-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | 솔루스첨단소재 주식회사 | 2024-07-04 | — | — | WO | disclosed |
| WO-2024136528-A1 | ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | 솔루스첨단소재 주식회사 | 2024-06-27 | — | — | WO | disclosed |
| CN-114507225-B | N-containing heterocyclic compound and application thereof in organic light-emitting device and panel | 上海天马微电子有限公司 | 2024-04-26 | — | — | CN | disclosed |
| US-20220223795-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | LT MATERIALS CO., LTD. (KR) | 2022-07-14 | — | — | US | disclosed |
| CN-114507225-A | N-containing heterocyclic compound and application thereof in organic light-emitting device and panel | 上海天马微电子有限公司 | 2022-05-17 | — | — | CN | disclosed |
| WO-2021045460-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | 엘티소재주식회사 | 2021-03-11 | — | — | WO | disclosed |
| US-10833277-B2 | Heterocyclic compound and organic light emitting diode comprising same | LG CHEM, LTD. (KR) | 2020-11-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10833277-B2 | Heterocyclic compound and organic light emitting diode comprising same | CRY1, CRY2, DDT | LIPG 2767/4885LPL 1290/4885P4HB 2516/4885 |
| US-20220223795-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | CRY1, CYP1A1, CYP1B1 | LIPG 3889/4885LPL 3423/4885P4HB 1954/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.